BioSpace News Archive

270Surgical Ltd. (the “Company”) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its SurroundScope System, the first laparoscopic camera system to offer up to 270-degree field-of-view (FoV).

Creative BioMart, a global specialized CRO providing high quality protein analytical services to support research, manufacturing and clinical development of native and recombinant proteins, is glad to enhance its protein kinase assay service recently to help customers accelerate their discovery and to help explore new frontiers in biological science.

G1 Therapeutics, Inc., a clinical-stage oncology company, provided a corporate and financial update for the third quarter ended September 30, 2019.

Principia Biopharma Inc., a late-stage biopharmaceutical company focused on developing novel therapies for immune mediated diseases, announced financial results for the third quarter ended September 30, 2019.

Avinger, Inc., a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease, reported results for the quarter ended September 30, 2019.

Akcea Therapeutics, Inc., a majority-owned affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious and rare diseases, reported financial results for the third quarter ended September 30, 2019.

Merus N.V. (Nasdaq: MRUS), a clinical-stage bispecific antibody company developing Biclonics®, today announced the pricing of an underwritten public offering of 4,750,000 common shares, at a public offering price of $14.50 per share, before underwriting discounts and commissions.

Yield10 Bioscience, Inc., an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the agriculture and food industries, announced that Kristi Snell, Ph.D., Yield10’s Chief Science Officer, will present at the 7th Plant Genomics & Gene Editing Congress.

Plyzer Technologies, Inc (“PLYZER” or “THE COMPANY”) is pleased to announce that it has signed Laboratorios Kin (“Kin”), a global leader in oral care healthcare products, as a new SaaS customer for its business intelligence software, Plyzer Intelligence.

Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association’s 2019 Workplace Health Achievement Index, ranking the company’s workplace health initiative among the best in the nation